Blueshift Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-23,368
Closed -$549K 884
2022
Q1
$549K Buy
+23,368
New +$572K 0.05% 410
2020
Q3
Sell
-12,756
Closed -$218K 707
2020
Q2
$218K Buy
+12,756
New +$189K 0.04% 462
2019
Q1
Sell
-12,743
Closed -$421K 848
2018
Q4
$421K Buy
+12,743
New +$512K 0.08% 391

Other funds holding MD

Blueshift Asset Management's MD Position: Q2 2022 in Review

Blueshift Asset Management sold out of Pediatrix Medical (MD) in Q2 2022, closing a stake of 23,368 shares — an estimated $549K sold.

Blueshift Asset Management first reported a position in MD in Q4 2018 and held it in 3 quarters. The position peaked at $549K in Q1 2022. 198 funds tracked by Wall St. Rank hold MD as of Q2 2022.

  • Blueshift Asset Management reported no remaining Pediatrix Medical position as of Q2 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 23,368 Pediatrix Medical shares in Q2 2022, an estimated $549K.
  • Blueshift Asset Management first reported a position in Pediatrix Medical in Q4 2018 and held it in 3 quarters.
  • Blueshift Asset Management's Pediatrix Medical position peaked at $549K in Q1 2022.
  • 198 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2022.

Based on Blueshift Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.